Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint…
Clinical
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Commercial
Prilenia Announces First Patient Enrolled for Pridopidine Phase 2/3 Platform Trial…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare…
Clinical
CannTrust Announces Launch of New Medical Brand estora – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA…
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium…
Home
Therapy areas
Therapy areas
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Commercial
Rakuten Medical to Present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021
Biospace News
-
January 11, 2021
Clinical
Ministry official: Egypt has received Sinopharm and AstraZeneca doses, will begin Sputnik V trials soon – FirstWord Pharma
Clinical
Mexico to get 400,000-500,000 Pfizer vaccines a week into March, president says – FirstWord Pharma
Clinical
Denmark close to securing enough Covid-19 vaccines for entire population – FirstWord Pharma
Clinical
Amneal Launches Generic Abiraterone Acetate Tablets, USP, 500 mg, Following ANDA Approval by FDA – FirstWord Pharma
Clinical
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium...
Firstwordpharma News
-
January 10, 2021
0
Clinical
U.S. FDA Approves Addition of Overall Survival and Other Secondary Endpoint...
Firstwordpharma News
-
January 10, 2021
0
Commercial
Greenwich LifeSciences to Participate in Multiple Virtual Investor Conferences During 2021...
Biospace News
-
January 8, 2021
0
Clinical
RespireRx Pharmaceuticals Inc. to Participate in Upcoming January Virtual Investor Conferences...
Globenewswire News
-
January 8, 2021
0
Acquisitions
Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program Nasdaq:CMRX
Globenewswire News
-
January 8, 2021
0
1
2
3
...
461
Page 1 of 461
- Advertisement -
MOST POPULAR
Zafgen Suspends Prader-Willi Syndrome Treatment, CMO Resigns
March 12, 2019
AKL Research & Development and Nordic Bioscience Collaborate to Take Novel...
May 2, 2019
Auris Medical Announces Closing of Two US Patent Acquisitions Related to...
May 15, 2019
TYME and The Joseph Ahmed Foundation Announce Initiation of the HopES...
May 23, 2019
Load more
HOT NEWS
NDA
KemPharm Submits KP415 NDA to the FDA for the Treatment of...
Commercial
Medexus Pharmaceuticals Reports Operating and Financial Results for the Second Quarter...
Others
Chi-Med Announces that Surufatinib Phase III SANET-ep Study Has Met its...
Deals
French Regulatory Agency Agrees lacutamab TELLOMAK Trial Can Resume Recruitment in...
